Related references
Note: Only part of the references are listed.Membrane dynamics in Leishmania amazonensis and antileishmanial activities of β-carboline derivatives
Lais Alonso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2021)
Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis
V Ramesh et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Antileishmanial activity of the chalcone derivative LQFM064 associated with reduced fluidity in the parasite membrane as assessed by EPR spectroscopy
Lais Alonso et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Analysis of the Interactions of Amphotericin B with the Leishmania Plasma Membrane Using EPR Spectroscopy
Lais Alonso et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2020)
The pore-forming action of polyenes: From model membranes to living organisms
Luka Kristanc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2019)
In vitro antileishmanial and cytotoxic activities of nerolidol are associated with changes in plasma membrane dynamics
Lais Alonso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2019)
Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis
Cristina de Castro Spadari et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Interactions of miltefosine with erythrocyte membrane proteins compared to those of ionic surfactants
Lais Alonso et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Antileishmanial and cytotoxic activities of ionic surfactants compared to those of miltefosine
Lais Alonso et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane
Karla Petit et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2019)
Visceral Leishmaniasis-Optimum Treatment Options in Children
Shyam Sundar et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
Anti-fungal and anti-leishmanial activities of pectin-amphotericin B conjugates
Gayathri P. Kothandaraman et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2017)
Cytotoxicity and anti-Leishmania amazonensis activity of Citrus sinensis leaf extracts
Andreza R. Garcia et al.
PHARMACEUTICAL BIOLOGY (2017)
Induction of Early Autophagic Process on Leishmania amazonensis by Synergistic Effect of Miltefosine and Innovative Semi-synthetic Thiosemicarbazone
Debora B. Scariot et al.
FRONTIERS IN MICROBIOLOGY (2017)
The cytotoxic activity of miltefosine against Leishmania and macrophages is associated with dynamic changes in plasma membrane proteins
Kelly Souza Fernandes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
Hemolytic potential of miltefosine is dependent on cell concentration: Implications for in vitro cell cytotoxicity assays and pharmacokinetic data
Lais Alonso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
Neil R. H. Stone et al.
DRUGS (2016)
An unbiased metric of antiproliferative drug effect in vitro
Leonard A. Harris et al.
NATURE METHODS (2016)
Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study
Maha M. Eissa et al.
PLOS ONE (2015)
In Vitro Metacyclogenesis of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Clinical Field Isolates, as Evaluated by Morphology, Complement Resistance, and Infectivity to Human Macrophages
Ildefonso Alves da Silva et al.
BIOMED RESEARCH INTERNATIONAL (2015)
An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment
Jacob Lorenzo-Morales et al.
PARASITE (2015)
Miltefosine Increases Lipid and Protein Dynamics in Leishmania amazonensis Membranes at Concentrations Similar to Those Needed for Cytotoxicity Activity
Rodrigo Alves Moreira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments
Daniel Michal Kaminski
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2014)
Amphotericin forms an extramembranous and fungicidal sterol sponge
Thomas M. Anderson et al.
NATURE CHEMICAL BIOLOGY (2014)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Amphotericin primarily kills yeast by simply binding ergosterol
Kaitlyn C. Gray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The in vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant Leishmania species of Brazil
Eliane de Morais-Teixeira et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2011)
Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities
Daniel S. Palacios et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Amphotericin B Membrane Action: Role for Two Types of Ion Channels in Eliciting Cell Survival and Lethal Effects
B. Eleazar Cohen
JOURNAL OF MEMBRANE BIOLOGY (2010)
Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
Victor Monforte et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
Complex formation of amphotericin B in sterol-containing membranes as evidenced by surface plasmon resonance
Ryota Mouri et al.
BIOCHEMISTRY (2008)
Anticancer alkylphospholipids: Mechanisms of action, cellular sensitivity and resistance, and clinical prospects
Wim J. van Blitterswijk et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci
Daniel Llull et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Hexadecylphosphocholine (Miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis
F Widmer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs
SL Croft et al.
TRENDS IN PARASITOLOGY (2003)
Antiprotozoal activities of phospholipid analogues
SL Croft et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2003)
Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours
M Crul et al.
EUROPEAN JOURNAL OF CANCER (2002)
Share Paper
